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Introduction
People with schizophrenia are at elevated risk of developing type 
2 diabetes. The prevalence of type 2 diabetes is more than two times 
greater in this population compared to the general population [1]. 
Enduring mental illness and chronic physical morbid conditions 
contribute to this double burden, not only to individuals but to 
society as a whole. Patients themselves and families and carers also 
experience lower quality of life and productivity losses. The total 
societal costs related to diabetes in the UK currently are £23.7 billion 
and are estimated to rise to £39.8 billion by 2035-2036.Around 10% 
of the National Health Service (NHS) budget is spent on diabetes [2]. 
In particular, older adults aged 40 and above are at increased risk of 
diabetes partly because of their long-term use of antipsychotics and 
advancing age [3].
Antipsychotic-induced weight gain may result in voluntary 
unplanned withdrawal of drug regimens, which in turn lead to higher 
relapse rates and incur more costs to health and social care services. 
Weight gain can negatively affect various aspects of individuals’ lives 
including physical health per se, as well as their body image, perception, 
confidence and social life. Increased metabolic risk factors are 
associated with other physical disorders such as cardiovascular diseases 
and reduced life expectancy of up to 10 years in people with type 2 
diabetes [4] and up to 15-20 years due to schizophrenia [5]. As a result 
of poor physical health, they are less likely to be employed. They are 
more dependent on social security benefits. 
Lifestyle interventions are effective for people with type 2 diabetes 
in the general population. Lifestyle interventions to promote physical 
activity and healthy eating habits though motivational interviewing 
techniques have been shown to be beneficial for people with mental 
health problems and comorbid somatic disorders [6]. Moreover, there 
is a growing number of studies on the clinical effectiveness of exercise, 
diet, psycho-social education, and counselling approaches or combined 
interventions of more than two of these components for people with 
severe mental illness. Recent systematic reviews suggest positive 
impacts on weight loss, BMI, glucose tolerance etc. [7,8]. 
Exercise alone is less effective than combined lifestyle interventions 
[9], while nutrition education alone does not make a significant 
difference in outcomes [10]. So combination therapy is more effective in 
achieving the desired outcomes. Multimodal approaches/multifactorial 
interventions are needed to meet the needs of people with complex 
needs.
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Abstract
Objective: People with schizophrenia are at elevated risk of having type 2 diabetes, compared to the general 
population. Although there is a growing body of literature on the effectiveness of behavioural interventions to improve 
physical activity levels and healthy eating habits, there are very few economic evaluations conducted for people 
with severe mental illness and physical health problems. The aim of this study is to explore the cost-effectiveness 
of group-based lifestyle interventions for middle-aged adults with enduring long-term schizophrenia and co-morbid 
type 2 diabetes.
Methods: Deterministic decision analytical modelling techniques are applied to explore cost-effectiveness 
based on the findings from a systematic review on this population. The intervention refers to a group-based lifestyle 
intervention, which is a combination of exercise, diet and diabetes education over 6 months. The intervention costs 
are estimated to reflect the UK local context. 
Results: From the UK National Health Service perspective, the group-based lifestyle intervention is potentially 
cost-effective, relative to usual care. It costs £80 to achieve an additional unit of Body Mass Index (BMI) lost and the 
incremental cost-effectiveness ratio is just below £700 to gain an extra Quality Adjusted Life Year, which lies well 
within the conventionally acceptable threshold values in the UK. 
Conclusions: Group based life style intervention for this population is effective and can be cost-effective in 
reducing BMI and improving diabetes knowledge, at least in the short-term. More co-ordinated policies among 
relevant sectors are required to facilitate behavioural change and better maintain an improved lifestyle. An integrated 
approach is needed to make this more sustainable in the long-term.
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In the UK, the physical health section of the most recent National 
Institute for Health and Care Excellence guideline [9] for people with 
psychosis or schizophrenia recommends that, those especially taking 
antipsychotics, should be offered a combined healthy eating and 
physical activity programme by their mental healthcare provider and 
regular monitoring of metabolic indicators in a primary care setting. 
But there is very limited economic evidence to justify the programme. 
In particular, it does not mention any specific strategy for particular 
sub-population groups including older adults who have both chronic 
schizophrenia and type 2 diabetes. The aim of this study is to explore 
the cost-effectiveness of group-based life style interventions for middle-
aged adults with chronic schizophrenia and co-morbid type 2 diabetes, 
using a decision modelling approach. Such a modelling approach could 
then be further utilised and adapted for different contexts and clinical 
settings.
Methods
Decision analytical models were constructed to explore cost-
effectiveness by comparing the costs and outcomes of group-based 
lifestyle intervention with usual care, using TreeAge Pro 2014 [11]. 
This kind of modelling approach can be helpful when there is limited 
availability of data from empirical studies such as randomised 
clinical trials or quasi-experimental settings. Although trial-based 
approaches can have better internal validity, they are more likely to be 
resource intensive and tend to take a longer time to identify clinically 
meaningful results. On the other hand, decision analytical models 
can be generated within a relatively shorter time period, compared to 
trial-based approaches. It is very useful when decision makers such 
as policymakers, commissioners and funders -need to know the most 
plausible outcomes given a relatively short time frame before making 
investment decisions on new interventions/programmes in the absence 
and/or a lack of long term empirical data . One of the advantages of 
the modelling approach is better external validity as the model can be 
adapted from one country setting to another and/or from inpatient care 
to outpatient care settings.
Intervention
The intervention was based on a diabetes awareness and 
rehabilitation training programme, consisting of twelve 90-minute 
sessions of a manualised healthy lifestyle programme over a six-month 
period. Modules of the programme included psycho-social education 
on diabetes, healthy eating habits and physical activity [12,13]. Self-
monitoring one important component of the programme which 
provided opportunities to learn about appropriate portion sizes for 
various food groups, reading food product labels, replacing sugary 
snacks with more fibre rich foods, as well as how to keep track of 
physical activity levels on a daily basis. For example, study participants 
could self-record their level of exercise using pedometers, which 
could facilitate their empowerment. Raffle tickets were offered to the 
participants as rewards to encourage their constant attendance. This 
intervention was compared with usual care. This refers to two General 
Practitioner (GP) visits with 20% of patients referred to dieticians. This 
is currently recommended as routine care in NICE guidance in the UK 
[9,14]. It does not include any specific component particularly targeted 
at people with both schizophrenia and diabetes.
Effectiveness data
Data regarding people with schizophrenia and type 2 diabetes 
were obtained from two studies in a systematic review [12,13,15]. Six 
months after the end of the studies, Body Mass Index (BMI) of service 
users receiving the programme reduced on average from 33.6 kg/m2 to 
32.9 kg/m2, while BMI of those receiving usual care was increased on 
average from 33.6 kg/m2 to 33.9 kg/m2 (p<0.001). Although the level 
of knowledge on diabetes in the intervention group slightly decreased 
at 12 months from 0.7 to 0.6, it was still higher than the value of 0.5 at 
the baseline, whereas there was nochange in the scores for the control 
group (p<0.001). Therefore, this indicates that sustainable skills were 
gained via the programme.
Costs
Intervention costs were estimated assuming 4 concurrent groups 
were run by one specialist educator with 6 to 8 participants per group per 
session. Four sessions for each of the three different topics on diabetes 
education, nutrition, and lifestyle exercise were run over 24 weeks (i.e. 
in total 12 sessions). Specialist mental health professional’s time costs 
of £107 were multiplied by 12 sessions to estimate the costs per group. 
Then these were multiplied by four concurrent groups. The total costs 
of £5136 were divided by the total maximum number of 32 participants 
in the experimental group. An extra £12 was added to individual costs 
as $20 was offered to all participants for the follow-up visit. Although 
other costs associated with running the sessions such as hourly rent for 
premises or use of pedometers, and overheads for printing hand-outs 
could be included, they are a relatively minor part of the total costs, as 
the total costs are mainly driven by human resource costs to implement 
the sessions. Cost associated with diabetes were considered; both costs 
of diabetes with complications or without complications, based on the 
data in the UK Prospective Diabetes Study and NICE guidelines [9,16]. 
Unit costs were obtained from the Personal Social Services Research 
Unit health and social care costs [17]. All costs were adjusted to 2012-13 
prices sterling pounds using the International Monetary Fund inflator. 
Discounting was not applicable as the time horizon was not beyond one 
year. Variables used in the model are presented in Table 1.
Cost-Effectiveness Analysis (CEA) vs. Cost-Utility Analysis 
(CUA)
In this study, the results are presented as in the form of cost-
effectiveness analysis and cost-utility analysis. To briefly explain the 
terms, cost-effectiveness analysis reports study results as cost per 
change in some form of clinical unit. In other words, it is related to the 
question of whether it is worth paying for an additional unit of benefit 
pernatural unit of outcome measure gained, in this case in terms of BMI 
loss achieved in this study. On the other hand, CUA presents the results 
as cost per Quality Adjusted Life Year (QALY) gained. That is to say; the 
cost of gaining one additional year of full quality life. -Incremental cost-
effectiveness ratios (ICERs) can act as summaries of the study findings. 
They can be expressed as the difference in costs against the difference 
in effects between the experimental and control groups (GL vs. UC).
Variables Values Source
Cost of Group-based lifestyle intervention (GL) £173 13
Cost of usual care (UC) £147 14 
Cost of diabetes without complications £115 9, 18
Cost of diabetes with complications £2120 9,18 
Probability of uptake in GL 0.53 12 
Probability of BMI loss achieved in GL 0.40 13 
Probability of BMI loss achieved in UC 0.15 13 
Utility scores of BMI loss achieved 0.80 9, 18, 19  
Utility scores of no BMI loss achieved 0.67 9, 19 
Table 1:  Parameters used in the model (£2013 prices).
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Decision tree model structure
A decision model is constructed to estimate the cost-effectiveness 
of the group-based life style intervention, relative to that of usual 
care for people aged 40 and over with chronic schizophrenia (mean 
duration of 17 years) and type 2 diabetes (mean duration of 8 years). 
They are allocated into two groups: one including group-based lifestyle 
intervention (GL) and the other usual care (UC). Participants in each 
group can choose to uptake the services or not and then BMI loss may or 
may not be achieved through intervention. In each care pathway, people 
incur different costs and have corresponding values of effectiveness 
over 6 months. The tree is ‘rolled back’ to reveal the expected values 
for cost-effectiveness of the group-based lifestyle intervention, relative 
to usual care. The model was constructed and analyses were performed 
using the Data pro 2014 version [11]. The structure of the model is 
illustrated in Figure 1.
Sensitivity analyses
Uncertainty around the parameters used in the model can be 
explored using deterministic analyses such as one (two)-way sensitivity 
analyses and/or more dynamic sensitivity analyses using Monte-Carlo 
simulation. Static analyses use a range of fixed values for variables of 
interests. One-way sensitivity analysis can be useful to see what impact 
one variable has on the results within the fixed range of the specific 
parameter. In two-way sensitivity analysis, the values for two variables 
selected from the model can be changed at the same time by defining 
the possible ranges. The region graph in the two-way sensitivity analysis 
can identify any possible changes in the optimal strategy, which may 
change the plausible conclusion of the findings at base case analysis 
when the values for the two parameters of interest can be varied. On 
the other hand, dynamic probabilistic analyses use distributions of 
parameters of interests, which can be varied by taking into account the 
values for mean and standard deviations to explore uncertainty around 
the values used in the model. 
Cost-effectiveness plane
In the cost-effectiveness plane, which will be used to report the 
results later, there are four quadrants including North West (NW), 
North East (NE), South West (SW) and South East (SE). The dots in the 
NE area indicate that a new intervention or programme is more costly 
and more effective, relative to the existing usual care or comparator(s) 
chosen for the analysis. Those in NW mean that a new intervention can 
be more costly and less effective, in which case economists would say 
that the new intervention is “dominated” by usual care. In other words, 
usual care should be a preferred choice. Dots in the SW quadrant 
indicate that the new intervention is less costly and less effective. Those 
in the SE area mean that the new intervention can be more effective and 
less costly, which is a “dominant” option. Especially when dots are in the 
NE and SW quadrants, they are more likely to involve judgements based 
on how much money that a society is willing to pay for the particular 
programme. In England, the threshold values are approximately 
between £20,000 and £30,000 per QALY gained, as recommended 
by NICE. But the ceiling values vary from country to country. For 
example, in the USA, the preferred value is $50,000 per QALY gained 
[20] and in most of the European countries, the acceptable threshold 
values are roughly €30,000/QALY. It should be born in mind that these 
conventionally accepted threshold values are not fixed in stone. Of 
course, they are flexible in a sense that there is room for reflecting local 
priorities, depending on epidemiological factors and how the health 
and social care systems are financed in different countries.
Results
Basecase
In the base case scenario, the difference in costs between GL and 
UC can be divided by the difference in effectiveness between the two 
groups to get the Incremental Cost-effectiveness Ratio (ICER). The 
results of the cost-effectiveness analyses can be positive as the ICER is 
£81.23 to achieve an extra unit of BMI loss. This will depend on how 
much a decision-maker is willing and able to pay for an improvement 
in this outcome as shown in Table 2.
much a decision-maker is willing and able to pay for an im
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−
Similarly, in Table 2 the results of the cost-utility analysis can be 
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Figure 1: Decision analytical model for group-based lifestyle intervention vs. usual care.
Cost BMI loss achieved      
Strategy cost effect incrCost incrEff ICER
Usual Care 1195.21 0.08 0.00 0.00 0.00
Group-based lifestyle intervention 1205.97 0.21 10.76 0.13 81.23
Cost per QALY gained      
Strategy cost effect incrCost incrEff ICER
Usual Care 1195.21 0.68 0.00 0.00 0.00
Group-based lifestyle intervention 1205.97 0.70 10.76 0.12 676.89
Table 2: Results of cost-effectiveness analysis and cost-utility analysis at base 
case (£2013 prices).
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interpreted as GL being a very cost-effective option as the ICER is just 
below £700, which lies well below the conventionally accepted threshold 
values of £20,000 to £30,000 per QALY in the UK.
Sensitivity analyses
Following the famous quote by George Box “Essentially, all 
models are wrong, but some are useful” [21]. Economic models are a 
simplification of reality based on what is available for the modelling 
exercise. Therefore it is very important to explore uncertainty around 
the parameters used in the model by varying the assumptions about 
the variables of interests to help us say how confident we are about the 
results. 
First, the costs of GL and UC are varied from the best scenario to 
the least optimistic scenario by assuming different unit costs applied to 
different health professionals’ time costs and also different ratios in a 
group session. When the 12-session programme with 4 groups is run by 
GP nurses in a primary care setting with an hourly rate of £34 (£51 for 
90 minutes), the intervention will cost £76.50 per participant. Similarly, 
if the programme is delivered by psychiatric nurses with an hourly rate 
of £35 (£52.50 per 90 minutes), the cost will be £78.75 per person in the 
intervention arm.
The minimum costs can be applied when 4 GP nurses run the 
sessions at £76.50 per participant, assuming 100% attendance rates 
for a group of 8 people. The maximum costs of £1,152 per person can 
be applied when interventions are delivered by non-specialists for 
behavioural activation, assuming £192 per hour face-to-face contact 
(£288 per 90 minutes) with 50% of attendance rates for 6 people per 
group. 
In a one-way sensitivity analysis, holding the costs of usual care 
constant and varying the costs of intervention from £75.50 to £1152, 
when primary care nurses or psychiatric nurses deliver the programmes, 
GL is a dominant strategy as GL is less expensive and more effective. 
At the maximum cost of £1,152, assuming 4 non-specialists deliver the 
behavioural activation programmes on a face- to- face contact basis 
with 50% attendance rates for 6 people in a group, the ICER is £62,249, 
which is no longer cost-effective, given the acceptable ICER of £30,000 
per QALY in England. However, when the cost of GL is £399.13, the 
ICER is £14,900/QALY and at the cost of £614.25 in GL per person, the 
ICER is £28,428, which is just below £30,000/QALY.
In a one-way sensitivity analysis, holding the intervention costs 
fixed, the cost of usual care can be varied from £69 to £658. The 
minimum cost can be applied when GP costs are assumed to be £27 per 
telephone consultation lasting 7.1 minutes, combined with referrals of 
20% these patients to dieticians. On the other hand, the maximum cost 
can be up to £658 when GP costs are assumed to be £292 per hour of 
patient contact, including out of surgery costs such as clinics and home 
visits plus the costs for referring 100% of patients to dieticians.
The ICERs range from £5,583 per QALY at the usual care cost of 
£69, assuming GP costs of £27 per telephone consultation lasting 7.1 
minutes, combined with 20% referrals to dieticians to usual care being 
dominated at £658 when GPs have visits to home or clinic plus 100% 
referral to dieticians. When the cost for usual care becomes £187, UC 
starts to become less effective and more costly, relative to GL.
Threshold analysis may be useful in the absence of empirical 
evidence to know when the results can be reversed from acceptable to 
less acceptable and vice versa. When an intervention or programme 
is under consideration for possible roll-out on a bigger scale than 
a small experimental setting to maximise the benefits from the 
intervention, it is important to know the optimal rate of uptake. Even 
if there is an intervention, which is proved to be clinically effective 
in a randomised controlled trial, if it is not used to the maximum 
capacity, the resource and costs for the implementation may not be 
efficiently used. Therefore the higher the uptake rate, the more cost-
effective the intervention is. 
In two-way sensitivity analysis, two parameters can be selected such 
as cost of GL and cost of UC. When the values for these two variables 
are changed in a simultaneous fashion within the defined ranges, the 
region as shown in Figure 2 can efficiently identify any possible changes 
in the optimal strategy that should be considered for recommendation 
as the values of the two parameters change. Thresholds are simply the 
diagonal line between two areas.
Probabilistic sensitivity analysis can explore the uncertainty around 
the parameters of interests by using the Monte-Carlo Simulation 
technique. In this study, the main difference between deterministic 
and probabilistic sensitivity analyses is assessed using distributions of 
parameters such as the cost of GL, UC, and the probability of uptake in 
the GL group and quality of life score associated with BMI loss achieved, 
instead of using the actual fixed values. Figure 3 shows the scatter plot 
of the simulated pairs of costs and effects after 1000 iterations. 
The cost-effectiveness plane as shown in Figure 3 illustrates the 
relative position of the new intervention, compared with existing usual 
care (from the origin). The graphical presentation of the simulated pairs 
indicates that most of the spots can be seen in the South area. While the 
dots in the SW quadrant indicate GL can be less costly and less effective, 
dots in the SE quadrant mean potentially that GL can be more effective 
and less expensive, which is a dominant strategy for the particular 
target population that we are looking at in this study.
At a willingness-to- pay of £20,000 per QALY gained, there is a 
52.8% likelihood of the intervention being cost-effective. Therefore a 
decision on whether a particular programme should be recommended 
for consideration depends on judgement in the local contextto reflects 
the needs and/ or priorities for the local sub-population groups. Cost- 
effectiveness analyses results can be used one as one of many inputs 
to feed into the complex decision making processes involving multiple 
stakeholders.
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Figure 2: Two-way sensitivity analysis for costs of group-based lifestyle 
intervention and usual care.
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Discussion
The results of decision tree models can be used to feed into 
the economic decision making process as one of the inputs when 
decision-makers need to make a strategic decision on whether a new 
intervention, relative to alternative existing care option(s), should 
be funded within a relatively short period of time given a lack of 
empirical trial-based data. The modelling process is a simplified 
version of reality as it is not possible to incorporate all the possible 
variables and it is often not possible to know for certain what it would 
happen in the absence of particular data on possible scenarios. So 
one of the key advantages of using decision-analytical modelling 
is that models can explore what would happen under different 
assumptions within a relatively short period of time in a less resource 
intensive manner. But they are greatly influenced by the assumptions 
behind the values of particular parameters. It can be a very useful 
tool to -show the likely scenarios when decision makers such as 
commissioners, funders and policy-makers look for help to make 
strategic investment decisions.
From the NHS perspective, in the base case analysis, a group-
based lifestyle intervention (GL) for middle-aged adults with chronic 
schizophrenia and type 2 diabetes is more effective at modest cost in 
achieving an additional case of BMI loss and gaining an extra QALY, 
compared with usual care. The incremental cost per QALY gained 
is less than £700, when it is assumed that each group session will be 
attended by eight people who will complete a 12-session course of the 
therapeutic intervention. However, even with a lower rate of attendance 
up to 25% in a group for 8 people, the intervention will remain cost-
effective at a willingness-to-pay of £30,000 per QALY.
Depending on the types of health care professionals, the 
intervention costs can be more costly or cost-effective. In the sensitivity 
analysis, it appears that the intervention costs can be minimised when 
the manualised lifestyle programme is run by nurses in GP surgeries 
or in mental health clinics. When primary care nurses or psychiatric 
nurses deliver the programmes, GL is a dominant strategy as GL 
is less expensive and more effective. When varying the costs of the 
intervention, the same effectiveness size is assumed as the differences in 
the effectiveness are not well studied so far when the interventions are 
delivered by different health professionals.
At the policy level, it is important to promote sustainable lifestyle 
changes over the long-term by reducing barriers to uptake of those 
interventions in term of addressing affordability issues and access to 
necessary care services. The positive lifestyle changes achieved through 
lifestyle programmes can be further enhanced when governments at 
the policy level can provide more strategic support in terms of offering 
food subsidies for healthy fruit and vegetables, enforcing tax policies on 
foods with excessive amounts of sugar and salt, legislating for healthy 
foods and providing safe places to exercise more in the community 
for people with complex needs such as those on low income or with 
competing priorities in daily life. 
The Canadian Population Health Survey (NPHS) from 1994/95 
to 2006/07 highlighted the social determinants of health including 
inadequate income, insecurity associated with food and housing 
conditions as being among the most significant contributors to diabetes 
by showing the strong links between deprivation and diabetes. People 
living in poverty had a 41% higher likelihood of developing type 2 
diabetes [22,23]. Similarly, Diabetes UK [3] also reported that women 
in England in the most deprived areasare four times more likely to have 
diabetes than those who live in the most affluent area. 
A review by de Hert et al. [1] reported health inequalities in terms 
of access to information and services for diabetes among people with 
severe mental illness. People with schizophrenia are less likely to 
receive diabetes education within the past 6 months [24]. As a result, 
they tend to end up incurring more costs related to hospitalisation 
to treat diabetes complications. To narrow the gap in the services 
for this population, government should take a more active role in 
implementing educational programmes for related health professionals 
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Figure 3:  Scatter plot of Monte Carlo simulation results on the cost-effectiveness plane for group-based lifestyle intervention vs. usual care model.
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such as GPs, nurses, and cardiologists, diabetologists, psychiatrists and 
other specialists at the system level. 
Conclusion
The mechanisms by which type 2 diabetes develops are interplay 
of genetic, biological, physical, social environmental factors. Although 
different antipsychotic drugs may have different levels of impact on 
metabolic risk factors, weight gain and diabetes, the mechanism for 
antipsychotic-induced diabetes is not clear [25]. However, lifestyle 
interventions were found to be effective, regardless of the type of 
antipsychotic drug and diabetes treatment regimens [12,13]. 
A group-based lifestyle intervention is a promising option for 
middle-aged adults with chronic schizophrenia and comorbid type 2 
diabetes, considering BMI loss achieved and QALYs gained. Refresher 
sessions may help prolong the beneficial effects accrued beyond 6 
months, but little is known empirically about the long-term benefits 
or about the level of continued participation in these sessions. Studies 
are also currently focusing on how to normalise changes in lifestyles 
so as to make it easier to maintain change in the long term, drawing 
on work done by behavioural psychologists [26]. However, in the 
UK, a study by Holt et al. [27] found that a behavioural treatment 
programme for overweight and obese people with severe mental illness 
found significant progressive improvements in average weight and BMI 
over a 8- year follow-up period without any suggestion of a plateau 
(p<0.0001). This indicates promise for people with severe mental 
illness and diabetes. More empirical studies are also needed to confirm 
the long term costs and benefits of the impact of these physical health 
interventions on outcomes and costs over a longer time period. The 
lack of studies so far is not surprising – the same finding was reported 
in a review of the costs and benefits of interventions tackling co-morbid 
diabetes and depression [28].
For policy and practice, it would be more cost-effective if the 
intervention can be run at larger clinics than individual GP practices 
to reach the critical mass to justify the efficient use of resources for 
the likely number of people with both schizophrenia and co-morbid 
diabetes. Clearly, there are additional intangible benefits from a 
lifestyle intervention when it is implemented through a group rather 
than on an individual basis in terms of enhancing social capital and 
social integration to the communities, to which study participants 
belong. Group settings can have positive impacts on motivation levels 
and improve attendance rates. A group session can reduce staffing 
time, and allow service users to discuss their challenges and celebrate 
their accomplishments together, encourage behavioural changes and 
therefore promote peer-support [27]. But these intangible benefits 
are methodologically challenging to capture in monetary terms. If 
incorporated, it makes intervention even more cost-effective.
It is also important to take more personalised approaches to 
promoting self-efficacy and service user empowerment alongside broad 
strategic guidance. There are arguments for adopting patient-tailored 
rather than guidance-led treatment strategies [29]. Reflecting service 
users’ choices by taking into account their personal circumstances and 
preferences in the future programmes may lead to more feasible and 
persistent behavioural changes. For instance, involving patients in the 
stage for the design of the programme can be one way to incorporate 
their preferences such as various types of exercise (indoor vs. outdoor 
sports, meditation/energy based slow movements vs. dynamic aerobic 
activities), monitoring by offline contacts vs. communications via 
mobile or internet in virtual community etc. This kind of bottom-up 
approach can allow more flexibility to refine the optimal policy for 
specific sub-populations and increase motivation levels of patients as 
an active service user.
Group based life style intervention for this population is effective 
and can be cost-effective in reducing BMI and improving diabetes 
knowledge at least in the short-term. More co-ordinated policies among 
relevant sectors beyond health care are required to facilitate behavioural 
changes and better maintain the improved lifestyle. More studies are 
needed to confirm cost-effectiveness in diverse ethnic groups, different 
age bands and with a longer term follow-up.
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